First dual-chamber leadless pacemaker implantation at Meitra United Heart Centre, Kasaragod: a regional milestone in an octogenarian with sick sinus syndrome: a case report
DOI:
https://doi.org/10.18203/2320-6012.ijrms20262206Keywords:
Leadless pacemaker, Dual-chamber pacing, Sick sinus syndrome, Octogenarian, Femoral vein thrombosis, Cardiac rhythm managementAbstract
Leadless pacemaker technology has advanced to enable dual-chamber atrioventricular synchronous pacing through implant-to-implant communication between two independent leadless devices. We report the first AVEIR dual-chamber leadless pacemaker implantation performed at Meitra United Heart Centre (MUHC), marking a regional milestone for Kasaragod, Kannur, Coastal Karnataka, and Goa. An 86-year-old woman presented with sick sinus syndrome complicated by tachy-brady syndrome and presyncopal episodes. She underwent successful implantation of a dual-chamber leadless pacemaker via femoral venous access under general anesthesia using the Innvolution Pinnacle Agile Cath Lab at MUHC. Optimal electrical parameters were achieved, with a right ventricular threshold of 0.5 V at 0.4 ms and impedance of 750 Ω, and a right atrial threshold of 1.0 V at 0.4 ms and impedance of 310 Ω. Device-to-device communication was 100%. Postoperatively, the patient developed left femoral vein thrombosis, which was managed with anticoagulation therapy, and she was discharged in stable condition. This case demonstrates that dual-chamber leadless pacing is feasible in an octogenarian with sick sinus syndrome and may serve as an alternative to conventional transvenous pacing systems, while emphasizing the need to consider vascular access complications such as femoral vein thrombosis during patient selection.
Metrics
References
Knops RE, Ip JE, Doshi R, Exner DV, Defaye P, Canby R, et al. One-Year Safety and Performance of a Dual-Chamber Leadless Pacemaker. Circ Arrhythm Electrophysiol. 2025;18(4):e013619. DOI: https://doi.org/10.1161/CIRCEP.124.013619
Tjong FV, Reddy VY. Permanent Leadless Cardiac Pacemaker Therapy: A Comprehensive Review. Circulation. 2017;135(15):1458-70. DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.025037
Knops RE, Reddy VY, Ip JE, Doshi R, Exner DV, Defaye P, et al. A Dual-Chamber Leadless Pacemaker. N Engl J Med. 2023;388(25):2360-70. DOI: https://doi.org/10.1056/NEJMoa2300080
Steinwender C, Khelae SK, Garweg C, Chan JYS, Ritter P, Johansen JB, et al. Atrioventricular Synchronous Pacing Using a Leadless Ventricular Pacemaker: Results from the MARVEL 2 Study. JACC Clin Electrophysiol. 2020;6(1):94-106. DOI: https://doi.org/10.1016/j.jacep.2019.10.017
Reynolds D, Duray GZ, Omar R, Soejima K, Neuzil P, Zhang S, et al. A Leadless Intracardiac Transcatheter Pacing System. N Engl J Med. 2016;374(6):533-41. DOI: https://doi.org/10.1056/NEJMoa1511643
Hayashi T, Shishido KS, Moriyama NM, Tobita KT, Murakami MM, Saito SS. Deep vein thrombosis after leadless pacemaker implantation. European Heart Journal. 2022;43(Suppl 2):ehac544.479. DOI: https://doi.org/10.1093/eurheartj/ehac544.479
Boveda S, Lenarczyk R, Haugaa KH, Iliodromitis K, Finlay M, Lane D, et al. Use of leadless pacemakers in Europe: results of the European Heart Rhythm Association survey. Europace. 2018;20(3):555-9. DOI: https://doi.org/10.1093/europace/eux381
Duray GZ, Ritter P, El-Chami M, Narasimhan C, Omar R, Tolosana JM, et al. Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study. Heart Rhythm. 2017;14(5):702-9. DOI: https://doi.org/10.1016/j.hrthm.2017.01.035
Grubman E, Ritter P, Ellis CR, Giocondo M, Augostini R, Neuzil P, et al. To retrieve, or not to retrieve: System revisions with the Micra transcatheter pacemaker. Heart Rhythm. 2017;14(12):1801-6. DOI: https://doi.org/10.1016/j.hrthm.2017.07.015
Downloads
Published
How to Cite
Issue
Section
